Susquehanna Fundamental Investments, LLC Hepion Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.14 - $1.58 $56,771 - $78,684	-49,800 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.39 - $2.1 $53,931 - $81,480	-38,800 Reduced 43.79%	49,800 $76,000
Q1 2021 May 17, 2021	BUY	$1.77 - $2.98 $156,822 - $264,028	88,600 New	88,600 $163,000
Q4 2020 Feb 16, 2021	SELL	$1.58 - $3.64 $24,572 - $56,609	-15,552 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.84 - $4.59 $44,167 - $71,383	15,552 New	15,552 $48,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.